We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Elevated Glucose Associated with Undetected Heart Damage

By LabMedica International staff writers
Posted on 23 Feb 2012
Print article
Elevated levels of glycated hemoglobin (HbA1) are associated with minute levels of the protein troponin T (cTnT), a blood marker for heart damage.

A high-sensitivity blood test has been used to detect levels of cTnT showed that the concentrations were tenfold lower than those found in patients diagnosed with a heart attack.

Scientists at the Johns Hopkins Bloomberg School of Public Health (Baltimore, MD, USA) tested the hypothesis that in persons without clinically evident chronic heart disease (CHD) or heart failure, chronic hyperglycemia, assessed by HbA1c, would be independently associated with subclinical myocardial injury measured by elevated cTnT. The cTnT was measured using a novel high-sensitivity assay; Elecsys Troponin T (hs-cTnT) with a lower limit of detection of 3.0 ng/L. Elevated hs-cTnT was defined as levels above 4 ng/L in a healthy subpopulation, which were 20 to 70 year old.

The scientists followed 9,662 participants from the Atherosclerosis Risk in Communities (ARIC) study. None of the participants had coronary heart disease or history of heart failure. Higher levels of HbA1c were associated in a graded fashion with elevated levels of high-sensitivity cTnT. This relationship was present at HbA1c levels even below the threshold used to diagnose diabetes. Using conventional tests, troponin T can be detected in 0.7% of the population and is associated with heart attacks and death. With the high-sensitivity Elecsys Troponin T test (Roche Diagnostics; Indianapolis, IN, USA) low levels of troponin were found in 66% of the study population.

Jonathan Rubin, MD, a lead author of the study, said, "Our study hints at other potential pathways by which diabetes and elevated glucose are associated with heart disease. Mainly, glucose might not only be related to increased atherosclerosis, but potentially elevated glucose levels may directly damage cardiac muscle." The study was published on January 31, 2012, in the Journal of the American College of Cardiology.

Related Links:

Johns Hopkins Bloomberg School of Public Health
Roche Diagnostics


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Malaria Test
STANDARD Q Malaria P.f/Pan Ag
New
Immunofluorescence Analyzer
MPQuanti

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.